Srinivas Vourganti to Predictive Value of Tests
This is a "connection" page, showing publications Srinivas Vourganti has written about Predictive Value of Tests.
Connection Strength
0.170
-
Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate-specific antigen (PSA)-based detection of prostate cancer in men without prior biopsies. BJU Int. 2015 Mar; 115(3):381-8.
Score: 0.027
-
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 2014 Feb 10; 32(5):431-7.
Score: 0.026
-
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol. 2013 Nov; 64(5):713-719.
Score: 0.025
-
Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol. 2014 Jan; 32(1):23.e9-13.
Score: 0.024
-
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer. BJU Int. 2012 Dec; 110(11 Pt B):E783-8.
Score: 0.024
-
Image guidance in the focal treatment of prostate cancer. Curr Opin Urol. 2012 Jul; 22(4):328-35.
Score: 0.023
-
Prostate-specific antigen/solvent interaction analysis: a preliminary evaluation of a new assay concept for detecting prostate cancer using urinary samples. Urology. 2011 Sep; 78(3):601-5.
Score: 0.022